Abstract
Although we often study patients with schizophrenia and make treatment inferences thereupon in study populations that exclude patients with comorbid psychiatric conditions, the latter group is a clinical conundrum and is more common than represented in clinical practice. This “greater than chance” co-occurrence is not by chance. Reasons for this are enumerated in this chapter. There are also clear implications for understanding and treatment of these complex presentations. This chapter sets the stage and focuses on core themes as exemplified by obsessive-compulsive symptoms.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Achim AM, Maziade M, Raymond E, Olivier D, Mérette C, Roy MA (2011) How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull 37(4):811–821
Buckley PF, Miller B, Lehrer D, Castle D (2009) Psychiatric comorbidities and schizophrenia. Schizophr Bull 35(2):383–402
Clarke MC, Tanskanen A, Huttunen MO, Cannon M (2013) Sudden death of father or sibling in early childhood increases risk for psychotic disorder. Schizophr Res 143(2–3):363–366
Cross-Disorder Group of the Psychiatric Genomics Consortium; Genetic Risk outcome of Psychosis (GROUP) Consortium (2013) Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381(9875):1371–1379
Cuthbert BN, Insel TR (2013) Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 11:125
Doyle M, Chorcorain AN, Griffith E, Trimble T, O’Callaghan E (2014) Obsessive compulsive symptoms in patients with Schizophrenia on Clozapine and with Obsessive Compulsive disorder: a comparison study. Compr Psychiatry 55(1):130–136
Eryilmaz G, Hizli Sayar G, Ozten E, Gogcegoz Gul I, Karamustafalioglu O (2013) Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia. Ann Gen Psychiatry 12(1):40
Frances AJ, Nardo JM (2013) ICD-11 should not repeat the mistakes made by DSM-5. Br J Psychiatry 203(1):1–2
Frias A, Palma C, Farrols N, Salvador A, Bonet J, Bernáldez I (2014) Psychopathology and quality of live among patients with comorbidity between schizophrenia spectrum disorder and obsessive-compulsive disorder: no evidence for a “schizo-obsessive” subtype. Compr Psychiatry 55(5):1165–1173
Frommann N, Stroth S, Brinkmeyer J, Wolwer W, Luckhaus C (2013) Facial affect recognition performance and event-related potentials in violent and non-violent schizophrenia patients. Neuropsychobiology 68(3):139–145
Hwang MY, Kim SW, Yum SY, Opler LA (2009) Management of schizophrenia with obsessive-compulsive features. In: Hwang MY, Nasrallah HA (eds) Psychiatric and physical comorbidity in schizophrenia. Psychiatr Clin North Am 32(4):835–851
Jones V, Steel C (2014) Examining vulnerability to intrusive memories in schizophrenia comorbid with post traumatic stress disorder. Schizophr Res 15(2):487–489
Kim SW, Lindenmayer J-P, Hwang MY (2013) Schizophrenia with obsessive-compulsive symptoms: clinical and conceptual issues. Psychiatr Ann 43(10):442–445
Landgraf S, Blumenauer K, Osterheider M, Eisenbarth H (2013) A clinical and demographic comparison between a forensic and a general sample of female patients with schizophrenia. Psychiatry Res 210(3):1176–1183
Michalopoulou PG, Konstantakopoulos G, Typaldou M, Papageorgiou C, Christodoulou GN, Lykouras L, Oulis P (2014) Can cognitive deficits differentiate between schizophrenia with and without obsessive-compulsive symptoms? Compr Psychiatry 55(4):1015–1021
Opler LA, Hwang MY, Opler MG (2013) Comorbidities in schizophrenia: challenges for researchers and clinicians. Psychiatr Ann 43(10):438–441
Pope MA, Joober A, Malla AK (2013) Diagnostic stability of first-episode psychotic disorders and persistence of comorbid psychiatric disorders over one year. Can J Psychiatry 58(10):588–594
Regier DA, Kuhl EA, Kupfer DJ (2013) The DSM-5: classification and criteria changes. World Psychiatry 12(2):92–98
Reynolds D, Mehta P, Nasrallah HA (2013) Evaluation and treatment strategies in patients with schizophrenia and comorbid depression. Psychiatr Ann 43(10):446–453
Surtees PG, Kendell RE (1979) The hierarchy model of psychiatric symptomatology: an investigation based on present state examination ratings. Br J Psychiatry 135:438–443
Swendsen J, Conway KP, Degenhardt L, Glantz M, Jin R, Merikangas KR, Sampson N, Kessler RC (2010) Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 105(6):1117–1128
Swets M, Dekker J, Van Emmerik-van Oortmerssen K, Smid GE, Smit F, de Haan L, Schoevers RA (2014) The obsessive compulsive spectrum in schizophrenia, a meta-analysis and meta-regression exploring prevalence rates. Schizophr Res 152(2–3):458–468
Tandon R (2012) The nosology of schizophrenia: toward DSM-5 and ICD-11. Psychiatr Clin North Am 35(3):557–569
Tsai J, Rosenheck RA (2013) Psychiatric comorbidity among adults with schizophrenia: a latent class analysis. Psychiatry Res 210(1):16–20
Waddington JL, Buckley PF (2013) Psychotic depression: an underappreciated window to explore the dimensionality and pathobiology of psychosis. Schizophr Bull 39(4):754–755
Wang M, Pei L, Fletcher PJ, Kapur S, Seeman P, Liu F (2010) Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization. Mol Brain 3:25
Whitton AE, Henry JD (2013) The relationship between sub-clinical obsessive-compulsive symptoms and social cognition in chronic schizophrenia. Br J Clin Psychol 52(2):115–128
Wobrock T, Falkai P, Schneider-Axmann T, Hasan A, Galderisi S, Davidson M, Kahn RS, Derks EM, Boter H, Rybakowski JK, Libiger J, Dollfus S, Lopez-Ibor JJ, Peuskens J, Hranov LG, Gaebel W, Fleischhacker WW, EUFES study group (2013) Comorbid substance abuse in first-episode schizophrenia: Effects on cognition and psychopathology in the EUFEST study. Schizophr Res 147(1):132–139
Zink M, Schirmbeck F, Rausch F, Eifler S, Elkin H, Solojenkina X, Englisch S, Wagner M, Maier W, Lautenschlager M, Heinz A, Gudlowski Y, Janssen B, Gaebel W, Michel TM, Schneider F, Lambert M, Naber D, juckel G, Krueger-Oezguerdal S, Wobrock T, Hasan A, Riedel M, Müller H, Klosterkötter J, Bechdolf A (2014) Obsessive-compulsive symptoms in at –risk mental states for psychosis: associates with clinical impairment and cognitive function. Acta Psychiatr Scand 130(3):214–226
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Buckley, P.F., Hwang, M.Y. (2015). Comorbid Psychiatric Disorders in Schizophrenia: More than Just a Chance Co-occurrence. In: De Haan, L., Schirmbeck, F., Zink, M. (eds) Obsessive-Compulsive Symptoms in Schizophrenia. Springer, Cham. https://doi.org/10.1007/978-3-319-12952-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-12952-5_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12951-8
Online ISBN: 978-3-319-12952-5
eBook Packages: MedicineMedicine (R0)